Nature's Sunshine Products, Inc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Nature's Sunshine Products, Inc with three other
companies in this sector in the United States:
Ionis Pharmaceuticals Inc
sales of $346.62 million
of which 104%
was Ionis core),
Ironwood Pharmaceuticals Incorporation
of which 100%
was Human Therapeutics), and
Pacira Pharmaceuticals Inc
of which 100%
was Depo Foam Drug Delivery Technology).
During the year ended December of 2016, sales at
Nature's Sunshine Products, Inc were $341.16 million.
increase of 5.1%
versus 2015, when the company's sales were $324.71 million.
Despite this increase, sales are still
below the level achieved in 2014, when Nature's Sunshine Products, Inc
reported sales of $366.37 million.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Nature's Sunshine Products, Inc had sales
of $367.81 million.
Sales of China and New Markets saw an increase
that was more than double the company's growth rate: sales were up
256.0% in 2016, from
$4.07 million to $14.47 million.
Nature's Sunshine Products, Inc also saw significant increases in sales in
Synergy Worldwide (up 9.4% to $124.79 million)
Not all segments of Nature's Sunshine Products, Inc experienced an increase in sales in 2016:
sales of Nsp Russia, Central and Eastern Europe fell 5.2% to $25.97 million.
Nature's Sunshine Products, Inc also experienced decreases in sales in
Nsp Americas (down 1.8% to $175.92 million)